These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 36403287)

  • 1. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
    Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
    Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-affirming pharmacotherapy and additional health considerations: A contemporary review.
    Mercer J; Bandy S; Tang H; Wenger B; Ryan L; Lee G; Lipscomb J
    J Am Pharm Assoc (2003); 2023; 63(6):1669-1676.e1. PubMed ID: 37619851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgenetic alopecia incidence in transgender and gender diverse populations: A retrospective comparative cohort study.
    Gao JL; Sanz J; Tan N; King DS; Modest AM; Dommasch ED
    J Am Acad Dermatol; 2023 Sep; 89(3):504-510. PubMed ID: 36780950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
    Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
    Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and Facilitators to Gender-affirming Hormone Therapy in the Veterans Health Administration.
    Wolfe HL; Boyer TL; Shipherd JC; Kauth MR; Jasuja GK; Blosnich JR
    Ann Behav Med; 2023 Nov; 57(12):1014-1023. PubMed ID: 37436725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review.
    Iwamoto SJ; Grimstad F; Irwig MS; Rothman MS
    J Gen Intern Med; 2021 May; 36(5):1380-1389. PubMed ID: 33547576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgender health and the impact of aging and menopause.
    Cheung AS; Nolan BJ; Zwickl S
    Climacteric; 2023 Jun; 26(3):256-262. PubMed ID: 37011669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial.
    Dijkman BAM; Helder D; Boogers LS; Gieles NC; van Heesewijk JO; Slaa ST; Liberton NPTJ; Wiepjes CM; de Blok CJM; den Heijer M; Dreijerink KMA
    BMC Pharmacol Toxicol; 2023 Dec; 24(1):80. PubMed ID: 38124194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
    Glintborg D; T'Sjoen G; Ravn P; Andersen MS
    Eur J Endocrinol; 2021 Jun; 185(2):R49-R63. PubMed ID: 34081614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgender patients and gender-affirming hormone therapy through the mid-life.
    Mehta JM; Kanell S; Borowicz CEA; Fisher MA
    Maturitas; 2024 Nov; 189():108093. PubMed ID: 39178607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults.
    Iwamoto SJ; Defreyne J; Kaoutzanis C; Davies RD; Moreau KL; Rothman MS
    Ther Adv Endocrinol Metab; 2023; 14():20420188231166494. PubMed ID: 37113210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
    Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B
    Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans.
    Hashemi L; Marijic Buljubasic A; Budoff MJ; Copeland LA; Jackson NJ; Jasuja GK; Gornbein J; Reue K
    JAMA Netw Open; 2024 Jul; 7(7):e2419696. PubMed ID: 38954413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone health in transgender assigned female at birth people: effects of gender-affirming hormone therapy and gonadectomy.
    Sanna E; Lami A; Giacomelli G; Alvisi S; Paccapelo A; Seracchioli R; Meriggiola MC
    Front Endocrinol (Lausanne); 2024; 15():1416121. PubMed ID: 39391880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast care considerations for transgender and gender-diverse patients.
    Carroll EF; Rogers C; Summerside M; Cortina CS
    Womens Health (Lond); 2024; 20():17455057241289706. PubMed ID: 39382481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory Changes During Gender-Affirming Hormone Therapy in Transgender Adolescents.
    Millington K; Lee JY; Olson-Kennedy J; Garofalo R; Rosenthal SM; Chan YM
    Pediatrics; 2024 May; 153(5):. PubMed ID: 38567424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people.
    Santi D; Spaggiari G; Marinelli L; Cacciani M; Scipio S; Bichiri A; Profeta A; Granata ARM; Simoni M; Lanfranco F; Manieri C; Ghigo E; Motta G
    J Endocrinol Invest; 2024 May; 47(5):1091-1100. PubMed ID: 37889433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-affirming hormone therapy and cardiovascular health in transgender adults.
    Ong C; Monita M; Liu M
    Climacteric; 2024 Jun; 27(3):227-235. PubMed ID: 38597210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Distinct Antiandrogen Exposures on the Plasma Metabolome in Feminizing Gender-affirming Hormone Therapy.
    Shepherd R; Angus LM; Mansell T; Arman B; Kim BW; Lange K; Burgner D; Kerr JA; Pang K; Zajac JD; Saffery R; Cheung A; Novakovic B
    J Clin Endocrinol Metab; 2024 Oct; 109(11):2857-2871. PubMed ID: 38609170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.